Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Baricitinib successfully treated severe hair loss.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Valproic acid can cause weight gain and hair texture changes.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Tacrolimus can cause hair loss in kidney transplant patients.

Precision neuromodulation may improve schizophrenia symptoms.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.